Intraoperative Mapping of Regional Lymphatics Draining the Primary Site of Melanoma Using Isosulfan Blue

ICG-Enabled Mapping of Ovarian Sentinel Lymph Nodes: A Feasibility Study

NCT04051502 ·Status: COMPLETED ·Phase: EARLY_PHASE1

MElanoma Research Lymph Node Prediction Implementation National_001

NCT04759781 ·Status: ACTIVE_NOT_RECRUITING

Melanoma Molecular Profiling Analysis

NCT00889980 ·Status: COMPLETED

Sentinel Lymph Node Biopsy for Cutaneous Squamous Cell Carcinoma of the Head and Neck

NCT05108090 ·Status: RECRUITING ·Phase: NA

A Non-Randomized Study to Evaluate Leg Lymphatic Drainage Associated With Surgical Intervention for Vulvar Cancer

NCT01321697 ·Status: TERMINATED

Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study

NCT05817149 ·Status: COMPLETED

Diagnostic Study to Predict the Risk of Developing Metastatic Cancer in Patients With Stage I or Stage II Melanoma

NCT00049010 ·Status: COMPLETED ·Phase: NA

Charcoal Carbon Black Dye Use in Sentinel Lymph Node Mapping in Early Stage Vulvar Cancer

NCT06694116 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Circulating Cell-free DNA in Metastatic Melanoma Patient: Mutational Analyses in Consecutive Measurement Before and After Chemotherapy

NCT02133222 ·Status: COMPLETED ·Phase: NA

Molecular Characterization of Advanced Stage Melanoma by Blood Sampling

NCT02862743 ·Status: COMPLETED ·Phase: NA

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testing for Assignment of Treatment

NCT01205815 ·Status: RECRUITING

Identification of Marker of Primary or Acquired Resistance to Anti Tumorous Treatment

NCT02105168 ·Status: UNKNOWN ·Phase: NA

Visceral Lymphatic Mapping Using Isosulfan Blue in Patients With Cancer of the Pancreas, Colon, Stomach, Small Intestine, or Gallbladder

NCT00489515 ·Status: COMPLETED

Detection of Plasmatic Cell-free BRAF and NRAS Mutations : a New Tool for Monitoring Patients with Metastatic Malignant Melanoma Treated with Targeted Therapies or Immunotherapy ( MALT )

NCT03493230 ·Status: COMPLETED ·Phase: NA

Metabolic Phenotypes in Melanoma

NCT05570227 ·Status: RECRUITING ·Phase: NA

Detection of SLN in Patients With Endometrial Cancer Undergoing Robotic Assisted Staging: Comparison of ISB and ICG

NCT02068820 ·Status: COMPLETED ·Phase: NA

Sentinel Lymph Node Mapping With Different Injection Sites of ICG in Endometrium Cancer

NCT06656949 ·Status: RECRUITING ·Phase: NA

Study of Tumor Tissue Samples From Patients With Stage I, Stage II, or Stage III Malignant Melanoma

NCT00991991 ·Status: TERMINATED

A Prospective Randomized Study Comparing Sentinel Lymph Node (SLN) Evaluation With Standard Pathological Evaluation for the Staging of Colon Carcinoma

NCT01623258 ·Status: COMPLETED

Validation of a Molecular Prognostic Test for Eye Melanoma

NCT00406120 ·Status: WITHDRAWN

Study of Circulating Tumoral DNA in Metastatic Choroidal Melanoma

NCT01334008 ·Status: COMPLETED ·Phase: NA

S9431: Studying Genes and Immune Response in Tumor Samples From Patients With Locally Advanced or Metastatic Melanoma

NCT00898183 ·Status: COMPLETED

SWOG-8947 Collecting and Storing Blood Samples From Patients With Previously Untreated Non-Hodgkin Lymphoma

NCT01000558 ·Status: COMPLETED

Culture and Characterization of Circulating Tumor Cells (CTC) in Melanoma and Other Cancers

NCT01528774 ·Status: COMPLETED

Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors

NCT07149207 ·Status: RECRUITING ·Phase: PHASE2